Photo Gallery



News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • JUNE 2021 Issue has been successfully launched on 1 June 2021.



Remya R. S.*, Shankari E. and K. Dhunmati


Corona virus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome corona virus 2 (SARS CoV-2) a newly discovered corona virus. Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Currently, there is no efficacious treatment option available for this deadly contagious disease and so drug repurposing is the only option for a faster recovery from COVID-19. Drug repurposing is a process of identifying new uses for approved or investigational drugs and it is considered as a very effective strategy for drug discovery as it involves less time and cost to find a therapeutic agent. The present review will focus on the repurposing efficacy of the currently used drugs against COVID-19 and their safety. Relevant articles with experimental studies conducted in-silico, in-vitro, in-vivo; clinical trials in humans, case reports, and news archives were selected for the review. Remdesivir, favipiravir, ribavirin, lopinavir, ritonavir, darunavir, arbidol, chloroquine, hydroxychloroquine, tocilizumab, interferons, dexamethazone Ivermectin, nafamostat, cepharanthine, statins and apilimod are the few drugs which have shown good inhibitory effects against the SARS-CoV2 invitro as well as in clinical conditions and they are reviewed in the present article.

Keywords: Drug- Repurposing, SARS-CoV-2, COVID-19, Corona virus, Pandemic.

[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More